New topical treatment for patchy hair loss
Treatments studied
Part of Skin clinical trials.
This study tests a new cream or lotion for people with patchy hair loss (alopecia areata) that covers less than half of the scalp. It aims to see if the treatment helps hair grow back in those patches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 6 years old or older.
- You have patchy hair loss (alopecia areata) covering less than half of your scalp.
- You have not used any hair loss treatment (topical or oral) in the last 3 months.
- You do not have total hair loss on your scalp or body.
- You do not have other causes of hair loss (like thyroid or immune system problems) or skin diseases in the affected area.
- You are not allergic to any of the treatment ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a methotrexate lotion or minoxidil lotion is better at regrowing hair in people with patchy hair loss on the scalp. You will use one of the treatments for a period of time, and the doctors will check your progress.
This trial compares a cholesterol-lowering cream (simvastatin) with a standard steroid cream to treat patchy hair loss from alopecia areata. It aims to find a gentler, more effective way to help hair regrow on the scalp.
This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).
This study compares two treatments for patchy hair loss on the scalp: a vitamin D-like cream (calcipotriol) and steroid injections (intralesional steroids). It aims to see which is more effective at regrowing hair in adults with less than half of the scalp affected.
This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.
This trial tests an experimental oral tablet (VC005) in teenagers with severe alopecia areata, a condition that causes patchy hair loss. The goal is to see if the drug is safe and may help regrow hair.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.